FMR1 and fragile X syndrome: For example, plasticity phenotypes, E:I imbalances and signaling pathway alterations (e.g., mTOR, ERK) in the Fmr1–/y mouse model for FXS are substantially different between cortex (including some evidence from PFC) and hippocampus [48].